| Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer (NCT02911467) | Rahul Aggarwal | 2016-11-08 |
| A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects (NCT06190340) | TenNor Therapeutics (Suzhou) Limited | 2016-11-08 |
| A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia (NCT03531060) | Integrative Research Laboratories AB | 2016-11-08 |
| Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC. (NCT03130881) | Beijing Pearl Biotechnology Limited Liability Company | 2016-11-08 |
| A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors (NCT03077607) | Pfizer | 2016-11-07 |
| TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma (NCT02927964) | Robert Lowsky | 2016-11-07 |
| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma (NCT02101905) | National Cancer Institute (NCI) | 2016-11-07 |
| Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers (NCT03005782) | Regeneron Pharmaceuticals | 2016-11-07 |
| Thiamine Supplementation in Patients With Septic Shock (NCT03122678) | The Cleveland Clinic | 2016-11-05 |
| Physiologic Effects of Steroids in Cardiac Arrest (NCT02790788) | University of Athens | 2016-11-04 |
| A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors (NCT02784795) | Eli Lilly and Company | 2016-11-04 |
| Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification (NCT02812693) | Joanne Jeter | 2016-11-04 |
| Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight (NCT02958085) | Novo Nordisk A/S | 2016-11-04 |
| A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers (NCT02934607) | AstraZeneca | 2016-11-04 |
| A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years (NCT02955160) | Pfizer | 2016-11-03 |
| Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma (NCT02881125) | University of Washington | 2016-11-03 |
| Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals (NCT02958982) | Rhizen Pharmaceuticals SA | 2016-11-03 |
| Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961 (NCT02860676) | University of California, San Diego | 2016-11-03 |
| Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism (NCT02966652) | Neurocrine UK Limited | 2016-11-03 |
| A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects (NCT03229291) | Biosplice Therapeutics, Inc. | 2016-11-03 |
| A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers (NCT04372719) | SGS Life Sciences, a division of SGS Belgium NV | 2016-11-02 |
| Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer (NCT02953782) | Gilead Sciences | 2016-11-02 |
| Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed (NCT02935361) | University of Southern California | 2016-11-02 |
| Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1 (NCT03011463) | Dr. R. Pfleger Chemische Fabrik GmbH | 2016-11-01 |
| A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension (NCT02929407) | Ferring Pharmaceuticals | 2016-11-01 |
| A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2) (NCT02872428) | Dr. Hasan Alam | 2016-11-01 |
| Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis (NCT02319616) | University of California, Davis | 2016-11-01 |
| tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment (NCT02958423) | Jean Schoenen | 2016-11-01 |
| To Determine Tolerability to Glucagon Infusion in Obese Subjects (NCT02817659) | AdventHealth Translational Research Institute | 2016-11-01 |
| Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg (NCT02955472) | GL Pharm Tech Corporation | 2016-11-01 |
| Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage (NCT02687191) | Pfizer | 2016-11-01 |
| Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis (NCT02871323) | Northwestern University | 2016-11-01 |
| First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects (NCT03103451) | Biocad | 2016-11-01 |
| Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC (NCT03360630) | Capital Medical University | 2016-11-01 |
| Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib (NCT02986100) | pharmaand GmbH | 2016-11-01 |
| The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB) (NCT02953847) | University of Cape Town | 2016-11-01 |
| A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis (NCT03029455) | Vertex Pharmaceuticals Incorporated | 2016-11-01 |
| Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea. (NCT02859350) | Sanaria Inc. | 2016-11-01 |
| Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation (NCT02947191) | Chinese Academy of Sciences | 2016-11-01 |
| Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK) (NCT02956993) | Proteon Therapeutics | 2016-11-01 |
| A Study of LY900014 Formulation in Healthy Participants (NCT02942654) | Eli Lilly and Company | 2016-11-01 |
| T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies (NCT02772198) | Sheba Medical Center | 2016-11-01 |
| Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL (NCT02757248) | Anne Beaven, MD | 2016-11-01 |
| Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (NCT02982915) | Longeveron Inc. | 2016-11-01 |
| Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies (NCT01553071) | South Plains Oncology Consortium | 2016-11-01 |
| Single-Dose PK Study of GBT440 in Subjects With Renal Impairment (NCT03161015) | Global Blood Therapeutics | 2016-11-01 |
| A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects (NCT02972125) | UCB Biopharma S.P.R.L. | 2016-11-01 |
| Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer. (NCT02922777) | University of Texas Southwestern Medical Center | 2016-11-01 |
| Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients (NCT02628132) | King Faisal Specialist Hospital & Research Center | 2016-11-01 |
| Transplantation of Autologous Bone Marrow Derived Stem Cells in Patients With Rheumatoid Arthritis (NCT03067870) | Stem Cells Arabia | 2016-11-01 |
| A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma (NCT02770378) | University of Ulm | 2016-11-01 |
| CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study (NCT02722551) | Edwards Lifesciences | 2016-11-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment (NCT02902679) | Bristol-Myers Squibb | 2016-11-01 |
| 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients (NCT03164837) | Peking Union Medical College Hospital | 2016-11-01 |
| Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02759731) | National Cancer Institute (NCI) | 2016-11-01 |
| A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept® (NCT02968719) | Corium, Inc. | 2016-11-01 |
| A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA) (NCT03005210) | Genuine Research Center, Egypt | 2016-11-01 |
| Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer (NCT02962063) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB (NCT02972697) | National University Hospital, Singapore | 2016-11-01 |
| TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus (NCT03002233) | Toray Industries, Inc | 2016-11-01 |
| A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects (NCT02962440) | Novo Nordisk A/S | 2016-11-01 |
| A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects (NCT02959060) | Bristol-Myers Squibb | 2016-11-01 |
| Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) (NCT02955810) | National University of Ireland, Galway, Ireland | 2016-11-01 |
| Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans (NCT02970786) | Rigshospitalet, Denmark | 2016-11-01 |
| A First-in-Human Study of BNZ132-1-40 (NCT03046459) | Bioniz Therapeutics | 2016-11-01 |
| CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia (NCT02975687) | Institute of Hematology & Blood Diseases Hospital, China | 2016-11-01 |
| Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males (NCT02962531) | Ixchelsis Limited | 2016-11-01 |
| Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma (NCT02792036) | St. Jude Children's Research Hospital | 2016-11-01 |
| Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease (NCT02995993) | Greenovation Biotech GmbH | 2016-11-01 |
| Kanitinib in Treating Patients With Advanced Solid Tumors (NCT02916095) | Beijing Konruns Pharmaceutical Co., Ltd. | 2016-11-01 |
| PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma. (NCT02867332) | Peking University | 2016-11-01 |
| The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis (NCT02291523) | Children's Hospital Los Angeles | 2016-11-01 |
| Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2 (NCT02907021) | Population Health Research Institute | 2016-11-01 |
| Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative (NCT03758287) | Sunshine Lake Pharma Co., Ltd. | 2016-11-01 |
| Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride (NCT02943213) | Cycle Pharmaceuticals Ltd. | 2016-11-01 |
| A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. (NCT02963909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-11-01 |
| VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers (NCT02955459) | Venatorx Pharmaceuticals, Inc. | 2016-11-01 |
| Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma (NCT02933073) | UConn Health | 2016-11-01 |
| Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02971397) | Wake Forest University Health Sciences | 2016-11-01 |
| A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate (NCT02952040) | Astellas Pharma Inc | 2016-11-01 |
| Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy (NCT02976402) | Fundacao Champalimaud | 2016-11-01 |
| Treatment Effect of Tamoxifen on Patients With DMD (NCT02835079) | Hadassah Medical Organization | 2016-11-01 |
| Phase I Study of SHR7390 in Patients With Advanced Solid Tumors (NCT02968485) | Jiangsu HengRui Medicine Co., Ltd. | 2016-11-01 |
| A Study in Healthy Volunteers and Patients With Chronic Hepatitis B (NCT02908191) | Assembly Biosciences | 2016-11-01 |
| Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC (NCT03001609) | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | 2016-11-01 |
| Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer (NCT02924233) | Symphogen A/S | 2016-11-01 |
| Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production (NCT02959710) | Cerecin | 2016-11-01 |
| A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia (NCT02527174) | University of Alberta | 2016-11-01 |
| Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC) (NCT02318147) | The First Affiliated Hospital of Nanchang University | 2016-11-01 |
| Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer (NCT03065010) | Biocad | 2016-11-01 |
| Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (NCT02446795) | Consorzio Oncotech | 2016-11-01 |
| A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects (NCT02957448) | Bristol-Myers Squibb | 2016-11-01 |
| Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects (NCT02954263) | Theravance Biopharma | 2016-11-01 |
| Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg (NCT02952937) | GL Pharm Tech Corporation | 2016-11-01 |
| A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours (NCT02977364) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2016-11-01 |
| Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin (NCT02956044) | Theracos | 2016-11-01 |
| First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects (NCT03103438) | Biocad | 2016-11-01 |
| A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed (NCT02722135) | Boehringer Ingelheim | 2016-11-01 |
| Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment (NCT02966340) | University of Wisconsin, Madison | 2016-11-01 |
| Ad-HGF Treatment for Myocardial Infarction (NCT02844283) | The First Affiliated Hospital with Nanjing Medical University | 2016-11-01 |